Author:
Moreau Michele,Richards Geraud,Yasmin-Karim Sayeda,Narang Amol,Deville Curtiland,Ngwa Wilfred
Abstract
IntroductionFiducials are routinely used to provide image-guidance during radiotherapy. Here, a new nanoparticle-based liquid immunogenic fiducial is investigated for its potential to provide image-guidance, while also enhancing treatment outcomes.MethodsThis fiducial, liquid immunogenic fiducial eluter (LIFE) biomaterial, is formulated with natural biodegradable polymers, chitosan and sodium alginate with radio-sensitizing nanoparticles, and immunoadjuvant like anti-CD40 monoclonal antibody. Once administered intra-tumorally, this liquid smart radiotherapy biomaterial congeals within the calcium rich tumor microenvironment. The potential use of LIFE biomaterial for providing image guidance in magnetic resonance imaging (MRI) and computed tomography (CT) was investigated over different time period in a pre-clinical tumored mouse model.ResultsResults showed that the LIFE biomaterial can provide both MRI contrast and CT imaging contrast over 3-weeks, with gradual decrease of the contrast over time, as the LIFE biomaterial biodegrades. Results also showed the LIFE biomaterial significantly slowed tumor growth and prolonged mice survival (p < 0.0001) over time.DiscussionThe results highlight the potential use of the LIFE biomaterial as a multi-functional smart radiotherapy biomaterial that could be developed and optimized for hypo-fractionated radiotherapy applications and combining radiotherapy with immunoadjuvants.
Funder
National Institutes of Health
Reference30 articles.
1. Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy;Habermehl;J Radiat Res,2013
2. Fiducial marker guided prostate radiotherapy: a review;O’Neill;Br J Radiol,2016
3. CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG oncology and TROG consensus guidelines;Brouwer;Radiother Oncol,2015
4. Fiducial markers visibility and artefacts in prostate cancer radiotherapy multi-modality imaging;Osman;Radiat Oncol,2019
5. Feasibility of a novel liquid fiducial marker for use in image guided radiotherapy of oesophageal cancer;de Blanck;Br J Radiol,2018
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献